TY - JOUR
T1 - Green Tea in Reproductive Cancers
T2 - Could Treatment Be as Simple?
AU - Parish, Maclaine
AU - Massoud, Gaelle
AU - Hazimeh, Dana
AU - Segars, James
AU - Islam, Md Soriful
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/2
Y1 - 2023/2
N2 - Green tea originates from the tea plant Camellia sinensis and is one of the most widely consumed beverages worldwide. Green tea polyphenols, commonly known as catechins, are the major bioactive ingredients and account for green tea’s unique health benefits. Epigallocatechin-3-gallate (EGCG), is the most potent catechin derivative and has been widely studied for its pro- and anti-oxidative effects. This review summarizes the chemical and chemopreventive properties of green tea in the context of female reproductive cancers. A comprehensive search of PubMed and Google Scholar up to December 2022 was conducted. All original and review articles related to green tea or EGCG, and gynecological cancers published in English were included. The findings of several in vitro, in vivo, and epidemiological studies examining the effect of green tea on reproductive cancers, including ovarian, cervical, endometrial, and vulvar cancers, are presented. Studies have shown that this compound targets specific receptors and intracellular signaling pathways involved in cancer pathogenesis. The potential benefits of using green tea in the treatment of reproductive cancers, alone or in conjunction with chemotherapeutic agents, are examined, shedding light on new therapeutic strategies for the management of female reproductive cancers.
AB - Green tea originates from the tea plant Camellia sinensis and is one of the most widely consumed beverages worldwide. Green tea polyphenols, commonly known as catechins, are the major bioactive ingredients and account for green tea’s unique health benefits. Epigallocatechin-3-gallate (EGCG), is the most potent catechin derivative and has been widely studied for its pro- and anti-oxidative effects. This review summarizes the chemical and chemopreventive properties of green tea in the context of female reproductive cancers. A comprehensive search of PubMed and Google Scholar up to December 2022 was conducted. All original and review articles related to green tea or EGCG, and gynecological cancers published in English were included. The findings of several in vitro, in vivo, and epidemiological studies examining the effect of green tea on reproductive cancers, including ovarian, cervical, endometrial, and vulvar cancers, are presented. Studies have shown that this compound targets specific receptors and intracellular signaling pathways involved in cancer pathogenesis. The potential benefits of using green tea in the treatment of reproductive cancers, alone or in conjunction with chemotherapeutic agents, are examined, shedding light on new therapeutic strategies for the management of female reproductive cancers.
KW - EGCG
KW - antioxidant
KW - cervical cancer
KW - endometrial cancer
KW - green tea
KW - ovarian cancer
KW - pro-oxidant
KW - reproductive cancers
UR - http://www.scopus.com/inward/record.url?scp=85147831541&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147831541&partnerID=8YFLogxK
U2 - 10.3390/cancers15030862
DO - 10.3390/cancers15030862
M3 - Review article
C2 - 36765820
AN - SCOPUS:85147831541
SN - 2072-6694
VL - 15
JO - Cancers
JF - Cancers
IS - 3
M1 - 862
ER -